17
Participants
Start Date
July 16, 2021
Primary Completion Date
August 22, 2021
Study Completion Date
October 1, 2021
BMS-986177 Oral Solution
Specified dose on specified days
[14C]BMS-986177 Solution for Infusion
Specified dose on specified days
BMS-986177 Spray-dried Dispersion Capsules
Specified dose on specified days
Local Institution, Nottingham
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY